Early work suggests that lysates analyzed by western blotting show good agreement with IHC when assessing HER2 overexpression48, and our results with animal and human tumor specimens which showed good concordance between western blotting and the EpiViewD4 assay are promising. The gene discussed is ERBB2; the disease is neoplasm.